Arthur Przybyl Latest Insider Activity
Management EfficiencyThe company has return on total asset (ROA) of 6.67 % which means that it generated profit of $6.67 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 0.07 % meaning that it created $0.07 on every $100 dollars invested by stockholders.
Entity SummaryANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States. ANI Pharmaceuticals, Inc. is headquartered in Baudette, Minnesota. ANI Pharmaceuticals operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 173 people.ANI Pharmaceuticals (ANIP) is traded on BATS Exchange in USA. It is located in MINNESOTA U.S.A and employs 173 people. ANI Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.
ANI Pharmaceuticals Leadership Team
Stock Performance Indicators